Send us a question about estate planning, retirement, or investing.
Have a question about estate planning, retirement, or investing? Send your question to Joel M. Blau, CFP, and Ronald J. Paprocki, JD, CFP, CHBC, c/o Urology Times. To submit your question, use the "Post a Comment" form below.
Prostate cancer genomic tests show prognostic value for progression, therapy benefit
April 22nd 2024"This preplanned ENACT trial biomarker analysis demonstrates the value of the Decipher score, AR-A score, and PAM50 genomic classifiers in identifying patients undergoing AS who are most likely to benefit from enzalutamide treatment," wrote the authors.